Skip to main content

Registry-Based Surveillance of Severe Acute Respiratory Infections in Norway During 2021-2024.

Influenza and other respiratory viruses2025-02-14PubMed
Total: 64.0Innovation: 6Impact: 7Rigor: 7Citation: 5

Summary

Among 214,730 SARI cases, testing coverage was high (82% SARS-CoV-2, 73% influenza, 53% RSV) and epidemic peaks were driven by these pathogens. Median time to ICD-10 coding was 5 days, while nowcasting and alternative case definitions improved timeliness, especially in younger populations where including URIs increased capture.

Key Findings

  • Identified 214,730 SARI cases; testing coverage was 82% for SARS-CoV-2, 73% for influenza, and 53% for RSV.
  • Median time from admission to SARI ICD-10 coding was 5 days (IQR 3–10); nowcasting and alternative case definitions improved timeliness.
  • ICD-10 codes for LRIs and COVID-19 captured only ~55% of cases in ages 0–29 compared with definitions including URIs.

Clinical Implications

Implement permanent registry-based SARI surveillance with nowcasting to detect surges early, guide ICU capacity, and tailor responses across age groups; include URI codes to improve case capture in younger populations.

Why It Matters

Demonstrates scalable, registry-based SARI surveillance integrating PCR data and nowcasting to support rapid situational awareness and resource allocation. It provides a blueprint for permanent national systems.

Limitations

  • Dependent on coding accuracy and completeness; limited clinical granularity and severity metrics
  • Temporary system; external validity to other health systems may vary

Future Directions

Establish permanent SARI surveillance with real-time dashboards; integrate outcomes (ICU, mortality), vaccination status, and genomic data to refine attribution and forecasting.

Study Information

Study Type
Cohort
Research Domain
Prevention
Evidence Level
III - Retrospective, nationwide registry-based cohort and system evaluation.
Study Design
OTHER